Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
Walgreens Boots Alliance (WBA) serves as a global leader in pharmacy-led healthcare and retail innovation. This news hub provides investors and industry professionals with essential updates on strategic initiatives, financial performance, and operational developments shaping this Fortune 500 company.
Access official press releases and curated analysis covering pharmacy services expansion, healthcare partnerships, and retail optimization strategies. Our repository includes updates on prescription care programs, wholesale distribution milestones, and regulatory developments impacting WBA's international operations.
Key categories include quarterly earnings disclosures, leadership changes, store network updates, and technological advancements in pharmaceutical distribution. Bookmark this page for streamlined tracking of WBA's progress in merging community pharmacy care with modern health solutions across 25+ countries.
InnerScope Hearing Technologies (OTC: INND) has launched its HearingAssist brand of FDA-Registered OTC Rechargeable Hearing Aids on Walgreens.com. This strategic move is part of InnerScope's B2B sales growth strategy, allowing them to reach millions of Walgreens customers. The HearingAssist Rechargeable OTC Hearing Aids, priced between $499 and $799, promise affordability and high-quality features, including Bluetooth connectivity. With over 500,000 hearing aids sold, InnerScope aims to dominate the OTC market by enhancing access to effective hearing solutions.
Walgreens Boots Alliance (WBA) reported its second quarter fiscal 2023 results, revealing a 20.3% decrease in EPS to $0.81, and a 27.2% drop in adjusted EPS to $1.16 due to reduced COVID-19 vaccine and testing volumes. Sales rose 3.3% year-over-year to $34.9 billion. Operating income plummeted to $0.2 billion from $1.2 billion in the previous year, reflecting a $306 million charge related to opioid claims and acquisition costs. Despite challenges, WBA maintains its full-year adjusted EPS guidance at $4.45 to $4.65, expecting growth in core business.
Walgreens confirms its commitment to dispensing Mifepristone where legally allowed, emphasizing adherence to FDA certification and compliance with federal and state laws. The company highlights its role in providing legally approved medications as part of its dedication to community health. Walgreens operates nearly 9,000 retail locations across the U.S., Puerto Rico, and the U.S. Virgin Islands, serving approximately 9 million customers daily. The pharmacy aims to integrate physical and digital platforms to enhance customer experience and meet community health needs.
Walgreens Boots Alliance (WBA) will announce its fiscal 2023 second quarter results on March 28, 2023 at 7 a.m. ET, followed by a conference call with management at 8:30 a.m. ET. The call will be streamed live via WBA's investor relations website. A replay will be available from 11:30 a.m. ET on the same day until April 4, 2023. With over 13,000 locations globally and employing 325,000 people, WBA continues to innovate in healthcare and retail, emphasizing its commitment to community health, sustainability, and digital services.
Walgreens, in collaboration with DoorDash and Uber, has launched a free, Same Day Rx Delivery service for HIV prevention and treatment medications. This service is now available to eligible patients within 15 miles of thousands of Walgreens pharmacies nationwide. This initiative aims to enhance healthcare access, particularly for those in underserved communities, aligning with the White House's National HIV/AIDS strategy targets to reduce new HIV infections significantly by 2030. The move follows previous efforts to provide COVID-19 treatment access, showcasing Walgreens' commitment to tackling health disparities.
Walgreens Boots Alliance (WBA) has sold approximately 15.5 million shares of Option Care Health (OPCH), raising funds at $30.75 per share. This includes 13.0 million shares in an underwritten secondary offering and a concurrent repurchase of 2.5 million shares by OPCH. Following the sale, WBA's ownership in OPCH decreased from 14% to 6%. The proceeds will primarily be allocated for debt paydown and to support WBA's strategic initiatives.
Walgreens is set to host a virtual Supplier Diversity Summit during the week of March 28, aimed at connecting diverse vendors with its merchandising team. This initiative seeks to enhance product offerings from suppliers who are at least 51% owned by disadvantaged groups, including minorities, veterans, and women. The summit will cover categories such as grocery, beauty, health, and wellness. Interested vendors can apply online to participate, fostering local and diverse product solutions for Walgreens' customers across the U.S. This event underscores Walgreens' commitment to meeting the needs of diverse communities.
On January 30, 2023, BetterInvesting Magazine named Lululemon Athletica Inc (NASDAQ: LULU) as its "Stock to Study" and Walgreens Boots Alliance Inc (NASDAQ: WBA) as its "Undervalued Stock" in the April 2023 issue. CEO Ken Zendel emphasized the magazine's role in educating investors, enhancing their market strategies. BetterInvesting offers tools and resources to assist investors in making informed decisions. In the April issue, readers can explore various stocks, while non-members can access trial online stock analysis tools. These selections are meant for informational purposes and do not constitute endorsements for purchase.
Walgreens Boots Alliance (WBA) has declared a quarterly dividend of 48 cents per share, consistent with the last quarter and reflecting a 0.5% increase from the previous year. The dividend will be payable on March 10, 2023, to shareholders of record on February 16, 2023. WBA has a strong history of dividend payments, having paid dividends for 361 consecutive quarters and increased them for 47 consecutive years. This commitment underscores the company's stability and dedication to returning value to investors.